Provides limitations on overlapping control between insurance companies and pharmacy benefits managers and pharmacies

2025 Regular Session Introduced by Jonathan Jacobson and 1 co-sponsor

A 9184 restricts cross-ownership among insurers, PBMs, and pharmacies to curb conflicts, boost transparency, and protect consumers and plan beneficiaries.

REFERRED TO INSURANCE

Summary of Assembly Bill A 9184

Overview

Bill Number: A 9184

Title: Provides limitations on overlapping control between insurance companies and pharmacy benefits managers (PBMs) and pharmacies

Status: Referred to Insurance

Introduced: October 17, 2025

Sponsor: Jonathan Jacobson (primary)

Purpose and Intent

A 9184 seeks to address concerns about potential conflicts of interest and reduced market competition arising from overlapping control among insurers, PBMs, and pharmacies. By limiting such overlaps, the bill aims to promote transparency, fair competition, and consumer protections within the health insurance and pharmacy services supply chain.

Key Provisions (High-Level)

Note: The exact language and specifics would be set forth in the bill text. Based on the title and summary provided, anticipated areas likely addressed include:
- Restrictions on cross-ownership and control: Limitations on ownership or control relationships that would place insurers, PBMs, and pharmacies under common influence.
- Definitions of “overlapping control”: Clarification of what constitutes control, and which entities are subject to the limits (e.g., insurers, PBMs, pharmacies, or other affiliated entities).
- Disclosure and governance requirements: Possible mandates for disclosure of ownership interests and/or management arrangements that create overlapping control.
- Prohibitions or thresholds: Potential caps or prohibitions on certain levels of ownership or joint ventures among these entities.
- Enforcement and penalties: Mechanisms to enforce the limitations, including penalties for violations and which agency would oversee compliance.
- Administrative and regulatory coordination: Provisions for implementing the limits, including reporting requirements and timelines for compliance.

Affected Parties

Insurance companies and their affiliates

Pharmacy benefit managers (PBMs)

Pharmacies (retail and mail-order)

Plan sponsors, employers, and beneficiaries who rely on insurer-PBM-pharmacy arrangements

Procedural Timeline and Next Steps

Introduced and first referred to the Assembly Committee on Insurance (October 17, 2025).

Legislative actions listed show the bill being referred to Insurance (duplicative entry noted in the record).

If advancing, the bill would typically undergo committee hearings, potential amendments, floor votes in the Assembly, and then movement to the Senate (if applicable) and further legislative steps.

Additional Notes

The current available information does not include the bill’s specific text or detailed provisions. For precise requirements, thresholds, penalties, and effective dates, the official bill text and any fiscal notes or committee reports should be consulted.

If you’d like, I can tailor this summary once the full text or official summaries are available, and pull out exact provisions, definitions, and timelines.